Biotech

All Articles

Halda's $126M is going to advance 'secure as well as kill' cyst medicines

.The preliminary phases of oncology R&ampD may not be except intriguing brand-new methods, and also ...

Lykos 'regrets' not disclosing study violations with publisher

.Psychopharmacology has drawn 3 posts about midstage clinical test data determining Lykos Therapeuti...

Analysts examine Avidity's DMD gain, uncovering distinctions in information

.Avidity Biosciences pleased investors along with stage 1/2 information in Duchenne muscle dystrophy...

Actinogen's cortisol blocker stops working phase 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually missed the primary endpoint of a stage 2 research...

Bivictrix determines going personal only means to take ADC into facility

.Antibody-drug conjugates (ADCs) have gone to the center of lots of a billion-dollar biobuck licensi...

TPG bests up funds to $580M for expenditures throughout life sciences

.Possession manager TPG, which has actually supported biotechs such as Sionna Therapies and also San...

Merck quits stage 3 TIGIT trial in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has endured another problem. Months after shuttering a phase 3 melano...

After a challenging year, Exscientia folds right into Recursion

.After a year specified through pipeline hairstyles, the shift of its chief executive officer and al...

Cullinan, after $25M bargain, hands back bispecific to Port

.Cullinan Therapeutics was actually impressed sufficient with Port BioMed's bispecific immune activa...

A better examine Tough Biotech's Ferocious 15

.Within this full week's incident of "The Leading Pipe," our experts are actually diving into Feroci...